Fuller Albright
Fuller Albright (January 12, 1900 – December 8, 1969) was an American endocrinologist who made significant contributions to the field of endocrinology and metabolism. He is best known for his work on bone diseases, parathyroid glands, and calcium metabolism. Albright's research led to the identification of several medical conditions, including Albright's syndrome, also known as McCune-Albright syndrome, which is characterized by uneven skin pigmentation, polyostotic fibrous dysplasia, and precocious puberty.
Early Life and Education[edit | edit source]
Fuller Albright was born in Buffalo, New York. He pursued his undergraduate education at Harvard College, where he developed an interest in biochemistry and medicine. After completing his bachelor's degree, Albright enrolled in Harvard Medical School, where he earned his M.D. in 1924. Following his graduation, he undertook further training and research at Massachusetts General Hospital in Boston, which would become the base for his lifelong research and clinical work.
Career and Contributions[edit | edit source]
Throughout his career, Albright made groundbreaking contributions to the understanding of metabolic bone diseases and the role of the parathyroid glands in calcium metabolism. His work on hyperparathyroidism and its link to bone disease laid the foundation for modern endocrinology. Albright's method of careful clinical observation combined with rigorous laboratory analysis allowed him to describe several new diseases, including:
- Albright's Syndrome (McCune-Albright Syndrome)
- Pseudohypoparathyroidism
- Primary Hyperparathyroidism
Albright was also instrumental in the development of the concept of osteomalacia and rickets as diseases related to vitamin D deficiency or metabolism.
Legacy[edit | edit source]
Fuller Albright's work has had a lasting impact on the field of endocrinology. He is remembered not only for his scientific contributions but also for his role as a mentor to a generation of endocrinologists. The Fuller Albright Award, established in his honor, is given annually by the American Society for Bone and Mineral Research to recognize outstanding scientific contributions in the field.
Selected Publications[edit | edit source]
Albright authored and co-authored more than 150 scientific papers. Some of his most notable publications include:
- "Hyperparathyroidism: A Common and Polymorphic Condition as Illustrated by Seventeen Proved Cases from One Clinic" (1934)
- "Pseudohypoparathyroidism: An Example of 'Seabright-Bantam Syndrome'" (1942)
- "Osteomalacia and Late Rickets: The Various Etiologies Met in the United States with Emphasis on that Resulting from a Specific Form of Renal Acidosis, the Therapeutic Indications for Each Etiological Subgroup, and the Relationship Between Osteomalacia and Milkman's Syndrome" (1946)
Death[edit | edit source]
Fuller Albright passed away on December 8, 1969, leaving behind a legacy that continues to influence the fields of endocrinology and metabolism.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD